Global Breakthrough Therapy (BT) Designation Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Global Breakthrough Therapy (BT) Designation Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Table of Contents

1 Breakthrough Therapy (BT) Designation Market Overview
1.1 Product Overview and Scope of Breakthrough Therapy (BT) Designation
1.2 Classification of Breakthrough Therapy (BT) Designation by Type
1.2.1 Global Breakthrough Therapy (BT) Designation Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Breakthrough Therapy (BT) Designation Revenue Market Share by Type in 2019
1.2.3 Oncology
1.2.4 Infectious Diseases
1.2.5 Rare Diseases
1.2.6 Autoimmune Diseases
1.2.7 Pulmonary Diseases
1.2.8 Neurological Disorders
1.2.9 Others
1.3 Global Breakthrough Therapy (BT) Designation Market by Application
1.3.1 Overview: Global Breakthrough Therapy (BT) Designation Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.3.5 Laboratories
1.4 Global Breakthrough Therapy (BT) Designation Market by Regions
1.4.1 Global Breakthrough Therapy (BT) Designation Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Breakthrough Therapy (BT) Designation (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Breakthrough Therapy (BT) Designation Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Breakthrough Therapy (BT) Designation Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Breakthrough Therapy (BT) Designation Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Breakthrough Therapy (BT) Designation Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Breakthrough Therapy (BT) Designation Status and Prospect (2015-2025)
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sanofi SWOT Analysis
2.2.4 Sanofi Product and Services
2.2.5 Sanofi Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.3 Janssen
2.3.1 Janssen Details
2.3.2 Janssen Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Janssen SWOT Analysis
2.3.4 Janssen Product and Services
2.3.5 Janssen Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.4 Abbvie
2.4.1 Abbvie Details
2.4.2 Abbvie Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Abbvie SWOT Analysis
2.4.4 Abbvie Product and Services
2.4.5 Abbvie Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.5 Gilead
2.5.1 Gilead Details
2.5.2 Gilead Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Gilead SWOT Analysis
2.5.4 Gilead Product and Services
2.5.5 Gilead Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis International AG
2.6.1 Novartis International AG Details
2.6.2 Novartis International AG Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis International AG SWOT Analysis
2.6.4 Novartis International AG Product and Services
2.6.5 Novartis International AG Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.7 Acadia
2.7.1 Acadia Details
2.7.2 Acadia Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Acadia SWOT Analysis
2.7.4 Acadia Product and Services
2.7.5 Acadia Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.8 Eli Lilly
2.8.1 Eli Lilly Details
2.8.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Eli Lilly SWOT Analysis
2.8.4 Eli Lilly Product and Services
2.8.5 Eli Lilly Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.9 BMS
2.9.1 BMS Details
2.9.2 BMS Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 BMS SWOT Analysis
2.9.4 BMS Product and Services
2.9.5 BMS Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.10 Regeneron
2.10.1 Regeneron Details
2.10.2 Regeneron Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Regeneron SWOT Analysis
2.10.4 Regeneron Product and Services
2.10.5 Regeneron Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.11 Vertex
2.11.1 Vertex Details
2.11.2 Vertex Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Vertex SWOT Analysis
2.11.4 Vertex Product and Services
2.11.5 Vertex Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.12 Jazz Pharmaceuticals
2.12.1 Jazz Pharmaceuticals Details
2.12.2 Jazz Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Jazz Pharmaceuticals SWOT Analysis
2.12.4 Jazz Pharmaceuticals Product and Services
2.12.5 Jazz Pharmaceuticals Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.13 Boehringer Ingelheim
2.13.1 Boehringer Ingelheim Details
2.13.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Boehringer Ingelheim SWOT Analysis
2.13.4 Boehringer Ingelheim Product and Services
2.13.5 Boehringer Ingelheim Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.14 Eisai
2.14.1 Eisai Details
2.14.2 Eisai Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Eisai SWOT Analysis
2.14.4 Eisai Product and Services
2.14.5 Eisai Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.15 Alexion
2.15.1 Alexion Details
2.15.2 Alexion Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Alexion SWOT Analysis
2.15.4 Alexion Product and Services
2.15.5 Alexion Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.16 GlaxoSmithKline
2.16.1 GlaxoSmithKline Details
2.16.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 GlaxoSmithKline SWOT Analysis
2.16.4 GlaxoSmithKline Product and Services
2.16.5 GlaxoSmithKline Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.17 Amgen
2.17.1 Amgen Details
2.17.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Amgen SWOT Analysis
2.17.4 Amgen Product and Services
2.17.5 Amgen Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.18 Exelixis
2.18.1 Exelixis Details
2.18.2 Exelixis Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Exelixis SWOT Analysis
2.18.4 Exelixis Product and Services
2.18.3 Exelixis Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.19 Merck
2.19.1 Merck Details
2.19.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Merck SWOT Analysis
2.19.4 Merck Product and Services
2.19.5 Merck Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.20 AstraZeneca
2.20.1 AstraZeneca Details
2.20.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 AstraZeneca SWOT Analysis
2.20.4 AstraZeneca Product and Services
2.20.5 AstraZeneca Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.21 Takeda
2.21.1 Takeda Details
2.21.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 Takeda SWOT Analysis
2.21.4 Takeda Product and Services
2.21.5 Takeda Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.22 Pfizer
3 Market Competition, by Players
3.1 Global Breakthrough Therapy (BT) Designation Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Breakthrough Therapy (BT) Designation Players Market Share
3.2.2 Top 10 Breakthrough Therapy (BT) Designation Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Breakthrough Therapy (BT) Designation Revenue and Market Share by Regions
4.2 North America Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
4.3 Europe Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
4.5 South America Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
5 North America Breakthrough Therapy (BT) Designation Revenue by Countries
5.1 North America Breakthrough Therapy (BT) Designation Revenue by Countries (2015-2020)
5.2 USA Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
5.3 Canada Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
5.4 Mexico Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
6 Europe Breakthrough Therapy (BT) Designation Revenue by Countries
6.1 Europe Breakthrough Therapy (BT) Designation Revenue by Countries (2015-2020)
6.2 Germany Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
6.3 UK Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
6.4 France Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
6.5 Russia Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
6.6 Italy Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Breakthrough Therapy (BT) Designation Revenue by Countries
7.1 Asia-Pacific Breakthrough Therapy (BT) Designation Revenue by Countries (2015-2020)
7.2 China Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
7.3 Japan Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
7.4 Korea Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
7.5 India Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
8 South America Breakthrough Therapy (BT) Designation Revenue by Countries
8.1 South America Breakthrough Therapy (BT) Designation Revenue by Countries (2015-2020)
8.2 Brazil Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
8.3 Argentina Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Breakthrough Therapy (BT) Designation by Countries
9.1 Middle East & Africa Breakthrough Therapy (BT) Designation Revenue by Countries (2015-2020)
9.2 Saudi Arabia Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
9.3 UAE Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
9.4 Egypt Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
9.5 South Africa Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Breakthrough Therapy (BT) Designation Revenue and Market Share by Type (2015-2020)
10.2 Global Breakthrough Therapy (BT) Designation Market Forecast by Type (2019-2024)
10.3 Oncology Revenue Growth Rate (2015-2025)
10.4 Infectious Diseases Revenue Growth Rate (2015-2025)
10.5 Rare Diseases Revenue Growth Rate (2015-2025)
10.6 Autoimmune Diseases Revenue Growth Rate (2015-2025)
10.7 Pulmonary Diseases Revenue Growth Rate (2015-2025)
10.8 Neurological Disorders Revenue Growth Rate (2015-2025)
10.9 Others Revenue Growth Rate (2015-2025)
11 Global Breakthrough Therapy (BT) Designation Market Segment by Application
11.1 Global Breakthrough Therapy (BT) Designation Revenue Market Share by Application (2015-2020)
11.2 Breakthrough Therapy (BT) Designation Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Research Institute Revenue Growth (2015-2020)
11.6 Laboratories Revenue Growth (2015-2020)
12 Global Breakthrough Therapy (BT) Designation Market Size Forecast (2021-2025)
12.1 Global Breakthrough Therapy (BT) Designation Market Size Forecast (2021-2025)
12.2 Global Breakthrough Therapy (BT) Designation Market Forecast by Regions (2021-2025)
12.3 North America Breakthrough Therapy (BT) Designation Revenue Market Forecast (2021-2025)
12.4 Europe Breakthrough Therapy (BT) Designation Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Breakthrough Therapy (BT) Designation Revenue Market Forecast (2021-2025)
12.6 South America Breakthrough Therapy (BT) Designation Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Breakthrough Therapy (BT) Designation Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Breakthrough Therapy (BT) Designation Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Breakthrough Therapy (BT) Designation by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Breakthrough Therapy (BT) Designation Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Breakthrough Therapy (BT) Designation Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Roche Corporate Information, Location and Competitors
Table 6. Roche Breakthrough Therapy (BT) Designation Major Business
Table 7. Roche Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 8. Roche SWOT Analysis
Table 9. Roche Breakthrough Therapy (BT) Designation Product and Solutions
Table 10. Roche Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Sanofi Corporate Information, Location and Competitors
Table 12. Sanofi Breakthrough Therapy (BT) Designation Major Business
Table 13. Sanofi Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2018-2019)
Table 14. Sanofi SWOT Analysis
Table 15. Sanofi Breakthrough Therapy (BT) Designation Product and Solutions
Table 16. Sanofi Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Janssen Corporate Information, Location and Competitors
Table 18. Janssen Breakthrough Therapy (BT) Designation Major Business
Table 19. Janssen Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 20. Janssen SWOT Analysis
Table 21. Janssen Breakthrough Therapy (BT) Designation Product and Solutions
Table 22. Janssen Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Abbvie Corporate Information, Location and Competitors
Table 24. Abbvie Breakthrough Therapy (BT) Designation Major Business
Table 25. Abbvie Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 26. Abbvie SWOT Analysis
Table 27. Abbvie Breakthrough Therapy (BT) Designation Product and Solutions
Table 28. Abbvie Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Gilead Corporate Information, Location and Competitors
Table 30. Gilead Breakthrough Therapy (BT) Designation Major Business
Table 31. Gilead Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 32. Gilead SWOT Analysis
Table 33. Gilead Breakthrough Therapy (BT) Designation Product and Solutions
Table 34. Gilead Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Novartis International AG Corporate Information, Location and Competitors
Table 36. Novartis International AG Breakthrough Therapy (BT) Designation Major Business
Table 37. Novartis International AG Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 38. Novartis International AG SWOT Analysis
Table 39. Novartis International AG Breakthrough Therapy (BT) Designation Product and Solutions
Table 40. Novartis International AG Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Acadia Corporate Information, Location and Competitors
Table 42. Acadia Breakthrough Therapy (BT) Designation Major Business
Table 43. Acadia Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 44. Acadia SWOT Analysis
Table 45. Acadia Breakthrough Therapy (BT) Designation Product and Solutions
Table 46. Acadia Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Eli Lilly Corporate Information, Location and Competitors
Table 48. Eli Lilly Breakthrough Therapy (BT) Designation Major Business
Table 49. Eli Lilly Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 50. Eli Lilly SWOT Analysis
Table 51. Eli Lilly Breakthrough Therapy (BT) Designation Product and Solutions
Table 52. Eli Lilly Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. BMS Corporate Information, Location and Competitors
Table 54. BMS Breakthrough Therapy (BT) Designation Major Business
Table 55. BMS Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 56. BMS SWOT Analysis
Table 57. BMS Breakthrough Therapy (BT) Designation Product and Solutions
Table 58. BMS Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Regeneron Corporate Information, Location and Competitors
Table 60. Regeneron Breakthrough Therapy (BT) Designation Major Business
Table 61. Regeneron Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 62. Regeneron SWOT Analysis
Table 63. Regeneron Breakthrough Therapy (BT) Designation Product and Solutions
Table 64. Regeneron Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Vertex Corporate Information, Location and Competitors
Table 66. Vertex Breakthrough Therapy (BT) Designation Major Business
Table 67. Vertex Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 68. Vertex SWOT Analysis
Table 69. Vertex Breakthrough Therapy (BT) Designation Product and Solutions
Table 70. Vertex Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Jazz Pharmaceuticals Corporate Information, Location and Competitors
Table 72. Jazz Pharmaceuticals Breakthrough Therapy (BT) Designation Major Business
Table 73. Jazz Pharmaceuticals Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 74. Jazz Pharmaceuticals SWOT Analysis
Table 75. Jazz Pharmaceuticals Breakthrough Therapy (BT) Designation Product and Solutions
Table 76. Jazz Pharmaceuticals Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 78. Boehringer Ingelheim Breakthrough Therapy (BT) Designation Major Business
Table 79. Boehringer Ingelheim Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 80. Boehringer Ingelheim SWOT Analysis
Table 81. Boehringer Ingelheim Breakthrough Therapy (BT) Designation Product and Solutions
Table 82. Boehringer Ingelheim Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Eisai Corporate Information, Location and Competitors
Table 84. Eisai Breakthrough Therapy (BT) Designation Major Business
Table 85. Eisai Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 86. Eisai SWOT Analysis
Table 87. Eisai Breakthrough Therapy (BT) Designation Product and Solutions
Table 88. Eisai Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Alexion Corporate Information, Location and Competitors
Table 90. Alexion Breakthrough Therapy (BT) Designation Major Business
Table 91. Alexion Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 92. Alexion SWOT Analysis
Table 93. Alexion Breakthrough Therapy (BT) Designation Product and Solutions
Table 94. Alexion Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. GlaxoSmithKline Corporate Information, Location and Competitors
Table 96. GlaxoSmithKline Breakthrough Therapy (BT) Designation Major Business
Table 97. GlaxoSmithKline Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 98. GlaxoSmithKline SWOT Analysis
Table 99. GlaxoSmithKline Breakthrough Therapy (BT) Designation Product and Solutions
Table 100. GlaxoSmithKline Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Amgen Corporate Information, Location and Competitors
Table 102. Amgen Breakthrough Therapy (BT) Designation Major Business
Table 103. Amgen Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 104. Amgen SWOT Analysis
Table 105. Amgen Breakthrough Therapy (BT) Designation Product and Solutions
Table 106. Amgen Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Exelixis Breakthrough Therapy (BT) Designation Type and Application
Table 108. Exelixis Breakthrough Therapy (BT) Designation Major Business
Table 109. Exelixis Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 110. Exelixis SWOT Analysis
Table 111. Exelixis Breakthrough Therapy (BT) Designation Product and Solutions
Table 112. Exelixis Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. Merck Corporate Information, Location and Competitors
Table 114. Merck Breakthrough Therapy (BT) Designation Major Business
Table 115. Merck Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 116. Merck SWOT Analysis
Table 117. Merck Breakthrough Therapy (BT) Designation Product and Solutions
Table 118. Merck Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 119. AstraZeneca Corporate Information, Location and Competitors
Table 120. AstraZeneca Breakthrough Therapy (BT) Designation Major Business
Table 121. AstraZeneca Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 122. AstraZeneca SWOT Analysis
Table 123. AstraZeneca Breakthrough Therapy (BT) Designation Product and Solutions
Table 124. AstraZeneca Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 125. Takeda Corporate Information, Location and Competitors
Table 126. Takeda Breakthrough Therapy (BT) Designation Major Business
Table 127. Takeda Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 128. Takeda SWOT Analysis
Table 129. Takeda Breakthrough Therapy (BT) Designation Product and Solutions
Table 130. Takeda Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 131. Pfizer Corporate Information, Location and Competitors
Table 132. Pfizer Breakthrough Therapy (BT) Designation Major Business
Table 133. Pfizer Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 134. Pfizer SWOT Analysis
Table 135. Pfizer Breakthrough Therapy (BT) Designation Product and Solutions
Table 136. Pfizer Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 137. Global Breakthrough Therapy (BT) Designation Revenue (Million USD) by Players (2015-2020)
Table 138. Global Breakthrough Therapy (BT) Designation Revenue Share by Players (2015-2020)
Table 139. Global Breakthrough Therapy (BT) Designation Revenue (Million USD) by Regions (2015-2020)
Table 140. Global Breakthrough Therapy (BT) Designation Revenue Market Share by Regions (2015-2020)
Table 141. North America Breakthrough Therapy (BT) Designation Revenue by Countries (2015-2020)
Table 142. North America Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2015-2020)
Table 143. Europe Breakthrough Therapy (BT) Designation Revenue (Million USD) by Countries (2015-2020)
Table 144. Asia-Pacific Breakthrough Therapy (BT) Designation Revenue (Million USD) by Countries (2015-2020)
Table 145. South America Breakthrough Therapy (BT) Designation Revenue by Countries (2015-2020)
Table 146. South America Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2015-2020)
Table 147. Middle East and Africa Breakthrough Therapy (BT) Designation Revenue (Million USD) by Countries (2015-2020)
Table 148. Middle East and Africa Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2015-2020)
Table 149. Global Breakthrough Therapy (BT) Designation Revenue (Million USD) by Type (2015-2020)
Table 150. Global Breakthrough Therapy (BT) Designation Revenue Share by Type (2015-2020)
Table 151. Global Breakthrough Therapy (BT) Designation Revenue Forecast by Type (2021-2025)
Table 152. Global Breakthrough Therapy (BT) Designation Revenue by Application (2015-2020)
Table 153. Global Breakthrough Therapy (BT) Designation Revenue Share by Application (2015-2020)
Table 154. Global Breakthrough Therapy (BT) Designation Revenue Forecast by Application (2021-2025)
Table 155. Global Breakthrough Therapy (BT) Designation Revenue (Million USD) Forecast by Regions (2021-2025)

List of Figures

Figure 1. Breakthrough Therapy (BT) Designation Picture
Figure 2. Global Breakthrough Therapy (BT) Designation Revenue Market Share by Type in 2019
Figure 3. Oncology Picture
Figure 4. Infectious Diseases Picture
Figure 5. Rare Diseases Picture
Figure 6. Autoimmune Diseases Picture
Figure 7. Pulmonary Diseases Picture
Figure 8. Neurological Disorders Picture
Figure 9. Others Picture
Figure 10. Breakthrough Therapy (BT) Designation Revenue Market Share by Application in 2019
Figure 11. Hospital Picture
Figure 12. Clinic Picture
Figure 13. Research Institute Picture
Figure 14. Laboratories Picture
Figure 15. Global Breakthrough Therapy (BT) Designation Revenue (USD Million) and Growth Rate (2015-2025)
Figure 16. North America Breakthrough Therapy (BT) Designation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Europe Breakthrough Therapy (BT) Designation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Asia-Pacific Breakthrough Therapy (BT) Designation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. South America Breakthrough Therapy (BT) Designation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Middle East and Africa Breakthrough Therapy (BT) Designation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Breakthrough Therapy (BT) Designation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Breakthrough Therapy (BT) Designation Revenue Share by Players in 2019
Figure 23. Global Top 5 Players Breakthrough Therapy (BT) Designation Revenue Market Share in 2019
Figure 24. Global Top 10 Players Breakthrough Therapy (BT) Designation Revenue Market Share in 2019
Figure 25. Key Players Market Share Trend
Figure 26. Global Breakthrough Therapy (BT) Designation Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 27. Global Breakthrough Therapy (BT) Designation Revenue Market Share by Regions (2015-2020)
Figure 28. Global Breakthrough Therapy (BT) Designation Revenue Market Share by Regions in 2018
Figure 29. North America Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 30. Europe Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 31. Asia-Pacific Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 32. South America Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 33. Middle East and Africa Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 34. North America Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2015-2020)
Figure 35. North America Breakthrough Therapy (BT) Designation Revenue Market Share by Countries in 2019
Figure 36. USA Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 37. Canada Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 38. Mexico Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 39. Europe Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2015-2020)
Figure 40. Europe Breakthrough Therapy (BT) Designation Revenue Market Share by Countries in 2019
Figure 41. Germany Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 42. UK Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 43. France Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 44. Russia Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 45. Italy Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2015-2020)
Figure 47. Asia-Pacific Breakthrough Therapy (BT) Designation Revenue Market Share by Countries in 2019
Figure 48. China Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 49. Japan Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 50. Korea Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 5

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs